Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Change in Cash: 2018-2024

Historic Change in Cash for Eton Pharmaceuticals (ETON) over the last 7 years, with Dec 2024 value amounting to -$6.5 million.

  • Eton Pharmaceuticals' Change in Cash rose 357.42% to $11.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.9 million, marking a year-over-year increase of 1032.01%. This contributed to the annual value of -$6.5 million for FY2024, which is 226.93% down from last year.
  • According to the latest figures from FY2024, Eton Pharmaceuticals' Change in Cash is -$6.5 million, which was down 226.93% from $5.1 million recorded in FY2023.
  • In the past 5 years, Eton Pharmaceuticals' Change in Cash registered a high of $9.2 million during FY2020, and its lowest value of -$6.9 million during FY2021.
  • In the last 3 years, Eton Pharmaceuticals' Change in Cash had a median value of $1.9 million in 2022 and averaged $176,667.
  • Its Change in Cash has fluctuated over the past 5 years, first spiked by 167.67% in 2023, then slumped by 226.93% in 2024.
  • Yearly analysis of 5 years shows Eton Pharmaceuticals' Change in Cash stood at $9.2 million in 2020, then crashed by 174.65% to -$6.9 million in 2021, then soared by 127.57% to $1.9 million in 2022, then skyrocketed by 167.67% to $5.1 million in 2023, then plummeted by 226.93% to -$6.5 million in 2024.